Source:http://linkedlifedata.com/resource/pubmed/id/20978268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-14
|
pubmed:abstractText |
FOXN1 deficiency is a primary immunodeficiency characterized by athymia, alopecia totalis, and nail dystrophy. Two infants with FOXN1 deficiency were transplanted with cultured postnatal thymus tissue. Subject 1 presented with disseminated Bacillus Calmette-Guérin infection and oligoclonal T cells with no naive markers. Subject 2 had respiratory failure, human herpes virus 6 infection, cytopenias, and no circulating T cells. The subjects were given thymus transplants at 14 and 9 months of life, respectively. Subject 1 received immunosuppression before and for 10 months after transplantation. With follow up of 4.9 and 2.9 years, subjects 1 and 2 are well without infectious complications. The pretransplantation mycobacterial disease in subject 1 and cytopenias in subject 2 resolved. Subject 2 developed autoimmune thyroid disease 1.6 years after transplantation. Both subjects developed functional immunity. Subjects 1 and 2 have 1053/mm(3) and 1232/mm(3) CD3(+) cells, 647/mm(3) and 868/mm(3) CD4(+) T cells, 213/mm(3) and 425/mm(3) naive CD4(+) T cells, and 10 200 and 5700 T-cell receptor rearrangement excision circles per 100 000 CD3(+) cells, respectively. They have normal CD4 T-cell receptor ? variable repertoires. Both subjects developed antigen-specific proliferative responses and have discontinued immunoglobulin replacement. In summary, thymus transplantation led to T-cell reconstitution and function in these FOXN1 deficient infants.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1528-0020
|
pubmed:author |
pubmed-author:AlbuquerqueAdriana SAS,
pubmed-author:ChinnIvan KIK,
pubmed-author:DebreMarianneM,
pubmed-author:DevlinBlythe HBH,
pubmed-author:FischerAlainA,
pubmed-author:MahlaouiNizarN,
pubmed-author:MarkertM LouiseML,
pubmed-author:MarquesJosé GJG,
pubmed-author:McCarthyElizabeth AEA,
pubmed-author:NevenBénédicteB,
pubmed-author:PicardCapucineC,
pubmed-author:PignataClaudioC,
pubmed-author:SilvaSusana LSL,
pubmed-author:SousaAna EAE,
pubmed-author:VictorinoRui MRM,
pubmed-author:de Saint BasileGenevièveG
|
pubmed:issnType |
Electronic
|
pubmed:day |
13
|
pubmed:volume |
117
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
688-96
|
pubmed:dateRevised |
2011-3-4
|
pubmed:meshHeading |
pubmed-meshheading:20978268-Cell Separation,
pubmed-meshheading:20978268-Female,
pubmed-meshheading:20978268-Flow Cytometry,
pubmed-meshheading:20978268-Forkhead Transcription Factors,
pubmed-meshheading:20978268-Humans,
pubmed-meshheading:20978268-Immunophenotyping,
pubmed-meshheading:20978268-Infant,
pubmed-meshheading:20978268-Male,
pubmed-meshheading:20978268-Severe Combined Immunodeficiency,
pubmed-meshheading:20978268-Thymus Gland
|
pubmed:year |
2011
|
pubmed:articleTitle |
First use of thymus transplantation therapy for FOXN1 deficiency (nude/SCID): a report of 2 cases.
|
pubmed:affiliation |
Department of Pediatrics, Duke University Medical Center, Durham, NC, USA. marke001@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|